Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Novartis Gene Therapies

Clinical trials sponsored by Novartis Gene Therapies, explained in plain language.

Now part of Novartis AG NVS NYSE

A subsidiary of Novartis focused on gene therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 4 Terminated 1

Gene therapy zolgensma tested in kids with SMA who can sit but not stand

Disease control Terminated

This phase 1 trial tested a gene therapy called AVXS-101 (Zolgensma) in 32 children with spinal muscular atrophy (SMA) who could sit but not stand or walk. The therapy delivers a working SMN gene via a spinal injection to help improve muscle function. The study focused on safety …

Phase: PHASE1 • Sponsor: Novartis Gene Therapies • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC